Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophrenia
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Positive symptoms of schizophrenia were diminished by neuroleptics and increased by amphetamine and accounted for most of the change seen in the total Brief Psychiatric Rating Scale (BPRS). Negative symptoms in the same subjects were not affected by neuroleptics but increased after amphetamines to a degree that just attained statistical significance. This increase was due to one item (emotional withdrawal) of the negative symptom factor which responded to neuroleptics and amphetamines as did positive symptoms. These findings are discussed with respect to new ideas about the role of dopamine in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Administration of stimulants to unmedicated schizophrenic patients can enhance positive symptoms (Angrist et al 1980, van Kammen et al 1982), which is likely due to subcortical D2 receptor activation.”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Angrist et al 1980, van Kammen et al 1982
Citations
Cites
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,856
CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Husband, J., & Kreel, L. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90890-4 · Cited by 1,253
The Dopamine Hypothesis of Schizophrenia: A Review*
Meltzer, H. Y., & Stahl, S. M. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.19 · Cited by 883
Kono, R., Miyamura, K., OGINO, T., Wadia, N. H., Wadia, P. N., Sm, K., & Vp, M. (1981) · PubMed · Cited by 578
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Carney, M. W. P., & Price, J. S. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90193-9 · Cited by 458
Hormones, Behavior, and Psychopathology
SACHAR, E. J. (1977) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197709000-00013 · Cited by 330
Weinberger, D. R. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140013001 · Cited by 323
The dementia of dementia praecox
Johnstone, E. C., Crow, T. J., Frith, C. D., Stevens, M., Kreel, L., & Husband, J. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb06899.x · Cited by 270
Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00427592 · Cited by 140
Self-citation
Research works printed but not linked: 1
- Guy W (1976) E.C.D.E.U. assessment manual for psychopathology. Washington D.C.: U.S. Department of Health, Education and Welfare, pp 160, 162, 167
Cited by
Items 301–371 of 371
Bailey, P., Duval, F., & Macher, J. P. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.5.699 · Cited by 3
What should a theory of schizophrenia be able to do?
Salzinger, K. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065328 · Cited by 3
“Positive” and “Negative” Movement Disorders in Schizophrenia
Sandyk, R., & Kay, S. R. (1992) · International Journal of Neuroscience · doi:10.1080/00207454.1992.12062310 · Cited by 3
The disabilities of chronic schizophrenia: A search for neurological correlates
Owens, D. G. C. (1985) · Enlighten: Theses (The University of Glasgow) · Cited by 3
Pharmacological approaches to cognitive enhancement
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.016 · Cited by 2
Groves, J. (2009) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10062 · Cited by 2
Biochemische Hypothesen zur Negativ-Symptomatik der Schizophrenie
Rao, M. L. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9349-5_11 · Cited by 2
Dopamine-GABA-cholinergic interactions and negative schizophrenic symptomatology
Sarter, M. F. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065341 · Cited by 2
Proverb interpretation in a schizotypal population
Allen, J. (1988) · ScholarWorks at University of Montana · Cited by 2
Negative Symptome und therapeutische Strategien bei Schizophrenie
Miller, D. D. (1992) · Springer eBooks · doi:10.1007/978-3-642-77843-8_6 · Cited by 2
Kielhold, M. L., Jacobs, D. S., Pacheco, A. T., Lefner, M. J., Bogachuk, A. P., Lebowitz, J. J., Langdon, A., Williams, J. T., Zweifel, L. S., & Moghaddam, B. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03632-1 · Cited by 1
Mathur, N. (2012) · Nottingham ePrints (University of Nottingham) · Cited by 1
Stimulant use disorders and psychosis: prevalence, correlates and impacts
Sara, G. E. (2014) · The University of Queensland · doi:10.14264/uql.2015.15 · Cited by 1
Don't leave the “psyche” out of neuropsychology
CLARIDGE, G. S., & Beech, T. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065079 · Cited by 1
Is another loop needed to explain schizophrenia?
Oke, A. F., & Adams, R. N. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065274 · Cited by 1
The limbic-striatal interaction: A seesaw rather than a tandem
Cools, A. R., & Ellenbroek, B. A. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065080 · Cited by 1
Hallucinations and contextually generated interpretations
Spaños, N. P. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046999 · Cited by 2
Schizophrenia and stored memories: Left hemisphere dysfunction after all?
Goldberg, E. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065171 · Cited by 1
A cardinal principle for neuropsychology, with implications for schizophrenia and mania
Hestenes, D. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065195 · Cited by 1
A neuropsychology of psychosis
Ingraham, L. J. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065213 · Cited by 1
内海, 晴., Ohta, I., Nishimura, N., & Ogura, C. (1993) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.24.469 · Cited by 1
Assessment of Psychopathology: Nosology and Etiology
Amir, N., & Feuer, C. A. (1998) · Elsevier eBooks · doi:10.1016/b0080-4270(73)00262-5 · Cited by 1
Dahl, S. G. (1987) · Psychiatry and Psychobiology · doi:10.1017/s0767399x00000936 · Cited by 1
Patterns of Clinical Efficacy for Antipsychotic Drugs
Golier, J. A., & Davidson, M. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61007-3_11
Assessment and treatment of cognitive impairment and related features
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.014
Behavior, Emotions, and the Law of Parsimony: Always Seek the Simple Explanation First
Rosenbluh, E. S. (2001) · Journal of Police Crisis Negotiations · doi:10.1300/j173v01n02_09
Herrold, A. A. (2011) · Loyola eCommons (Loyola University of Chicago)
Neural basis of context processing dysfunction in schizophrenia: a monkey model
Blackman, R. K. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Naber, D., Albus, M., Müller-Spahn, F., Münch, U., Bürke, H., Welter, D., & Ackenheil, M. (1984) · Springer eBooks · doi:10.1007/978-3-642-69539-1_32
Antipsychotic medications: linking receptor antagonist properties to neuropsychological functioning
Neilson, H. K. (2010) · Summit (Simon Fraser University)
Animal Models of Schizophrenia: Focus on Hippocampal Disruption of Dopamine System Regulation
Grace, A. A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0913-8_9
Fuoco, F. J., Naster, B. J., Vernon, J. B., Morley, R. T., Smith, B. L., & Cancelliere, A. E. B. (1986) · Behavioral Interventions · doi:10.1002/bin.2360010303
Dopaminergic excess or dysregulation?
Early, T. S., Haller, J., & Posner, M. I. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065134
A heuristically useful but empirically weak neuropsychological model of schizophrenia
Pisa, M., & Cleghorn, J. M. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065304
Neuroleptic-Resistant Schizophrenics
Murray, J. B. (1989) · The Journal of Psychology · doi:10.1080/00223980.1989.10542963
A focalized deficit within an elegant system
Elkins, I. J., & Cromwell, R. L. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065146
The significance of the basal ganglia for schizophrenia
Sandyk, R., & Kay, S. R. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0006533x
Raine, A., & Cannon, T. D. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065316
An investigation into the amphetamine model of psychosis in healthy volunteers
Albrecht, M. A. (2012) · UWA Profiles and Research Repository (UWA)
Verlaufsuntersuchungen bei Neuroleptikatherapie
Barocka, A., Höll, R., Jäck, C., Beck, G., & Pichl, J. (1988) · Springer eBooks · doi:10.1007/978-3-642-83488-2_11
Positive and Negative Symptoms in Schizophrenia and Their Neuropsychological Correlates
Tsang, M. H.-P. (1993) · University of North Texas Digital Library (University of North Texas)
A computerized tomographic evaluation of brain morphology in first episode psychotic patients
Smith, G. N. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0097327
The role of catechol-O-methyltransferase (COMT) in hippocampal function
Laatikainen, L. M. (2010) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-0o40y2qz5
The neuropsychology of schizophrenia: In step but not in time
Williams, J. H. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065419
Positiwe and negatiwe symptoms, the hippocampus and P3
Venables, P. H. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065390
An Investigation of Short-Term Memory Functioning in a Neurodevelopmental Rat Model of Schizophrenia
Moyett, A. (2015) · Seton Hall University eRepository (Seton Hall University)
A plausible theory marred by certain inconsistencies
Spohn, H. E. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065365
Pharmacological properties of tricyclic antidepressants and the treatment of somatic disorders
Kanba, S., & Richelson, E. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.724
Definition, Diagnostik und Therapie schizophrener Minussymptomatik
Müller-Spahn, F., Hock, C., & Kurtz, G. (1995) · Springer eBooks · doi:10.1007/978-3-642-93565-7_4
Becker, M. L. (2016) · CSUSB ScholarWorks (California State University, San Bernardino)
Multimodal Imaging of the Salience Network in Schizophrenia
Kumar, J. (2018) · Nottingham ePrints (University of Nottingham)
Differential diagnosis of autism spectrum disorder and early onset schizophrenia: two clinical cases
Martin, A. M., Stavropoulos, K. K. M., & Blacher, J. (2020) · Advances in Autism · doi:10.1108/aia-11-2019-0043
Ihalainen, J. A. (2005) · UEF eRepo (University of Eastern Finland)
Wehr, M. C. (2018) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.26238
Tagore, A. (2019) · TSpace (University of Toronto)
As bases biológicas da Esquizofrenia
Prata, D. P. (2015) · Imprensa da Universidade de Coimbra eBooks · doi:10.14195/978-989-26-0852-5_1
(2016) · Wiley eBooks · doi:10.1002/9781394259472.refs
Auditive hallusinasjoner - forståelse og behandling
Vatnan, K. G. (2013) · NORA - Norwegian Open Research Archives
Residual and Negative Symptoms in Treatment with Neuroleptics
Kane, J. M. (1993) · Springer eBooks · doi:10.1007/978-3-642-78010-3_13
Hada, K., Wulaer, B., Nagai, T., Itoh, N., Sawahata, M., Sobue, A., Mizoguchi, H., Mori, D., Kushima, I., Nabeshima, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13633089
The Impact of Amphetamine and Cannabis Use on the Symptoms and Clinical Course of Early Psychosis
Geppert, L. (2008) · Griffith Research Online · doi:10.25904/1912/1713
Hada, K., Wulaer, B., Nagai, T., Itoh, N., Sawahata, M., Sobue, A., Mizoguchi, H., Mori, D., Kushima, I., Nabeshima, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13633086
Caractérisation du sommeil de patients schizophrènes jamais traités avec des neuroleptiques
Poulin, J. (2001) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/27020
Aguirre Pacheco, C. I., & Legal, U. A. D. B. D. D. P. I. D. M. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Performance of Psychiatric and Head Injury Patients on the General Neuropsychological Deficit Scales
Collingwood, L. M. (1997) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc278771
Responsivity of Negative Symptoms to Typical Neuroleptic Drugsin Schizophrenia
Srivastava, J., Okazaki, Y., & Nakane, Y. (1996) · Acta medica Nagasakiensia
Substance use and psycholsis: an exploratory study
Baldwin, A. (2003) · Repository@Hull (Worktribe) (University of Hull)
Metadata
- Authors
- Angrist, B., Rotrosen, J., & Gershon, S.
- Affiliations
- United States Department of Veterans Affairs (US)
- Wayne State University (US)
- ORCID
- Rotrosen, J.
- Venue
- Psychopharmacology
- Published
- 1980-12
- Volume
- 72
- Issue
- 1
- Pages
- 17-19
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2050121560
- Cited by
- 344
- References
- 11
- Citations by year
- 2026: 1 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 4 · 2012: 8
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- amphetamine, antipsychotic drugs, schizophrenia, negative symptoms, positive symptoms, Brief Psychiatric Rating Scale, emotional withdrawal, dopamine, psychopharmacological effects
- MeSH terms
- Adult, Affect, Dextroamphetamine, Dopamine, Female, Haloperidol, Humans, Male, Psychiatric Status Rating Scales, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.